Beacon Pharmaceuticals Limited is a public company listed on the Dhaka and Chittagong Stock Exchange and one of the fastest growing companies of Bangladesh. We started operation in 2006 and have over 1600 employees. Currently Beacon is ranked number one in oncology and is one of the top tier pharma companies of Bangladesh.
Beacon has modern high quality infrastructure and facilities developed and engineered by European consultants to conform world class standards like US FDA, UK MHRA, Australian TGA and WHO-GMP.
Our facilities are equipped with some of the latest machines to manufacture specialized dosage forms like lyophilized, pre-filled, large volume parenterals, and fat emulsion alongside conventional tablet, capsule, liquid products. Beacon manufactures about 200 patented and off-patented generic drugs which include life saving anti-cancer, biotech, hepatitis, cardiovascular, and antibiotic medications.
We manufacture world class products at our world class facilities which you can see below.
We have an excellent R & D facility with a highly skilled and professional team who have been instrumental in our bringing generic versions of critical hepatitis C medications to market.
After meeting the local demand, we export our products to Asia, Africa & Latin American countries. Our oncology products are highly popular in Nepal, Sri Lanka, and the Philippines.
To meet the need of global patients, Beacon serves global prescriptions through their B2C wing at a very nominal price. As a service to global community, we will introduce more life saving drugs and will continue to offer exceptional pricing. By way of example, for the price of a single tablet of Harvoni® we can offer a complete 84 day course of generic medication.
Beacon is expanding its network globally and would like to work with global partners with strong marketing network.